TNF and obesity due to melanocortin 4 receptor deficiency: Further, investigations assessing the impact of anti-TNF agents on intermediary metabolism seemed to show that a TNF-alpha blockade may improve insulin resistance and lipid profiles, which in turn appeared to be associated with overweight and obesity.